Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hengyan Kuntai Capsules for diminished ovarian reserve during assisted reproduction
ChiCTR2400085366Phase 4Not yet recruiting
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- Jun 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Hengyan Kuntai Capsules in Diminished Ovarian Reserve (DOR) (2 arms), sponsored by Obstetrics and Gynecology Hospital of Fudan University. Primary endpoints: Antral follicle count and Anti-Müllerian hormone. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
Hengyan Kuntai Capsules
03
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on ChiCTR2400085366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085366.